As of 3:59pm ET
| +0.03 / +1.72%|
The 1 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a -15.25% decrease from the last price of 1.77.
The current consensus among 1 polled investment analysts is to Buy stock in Bio Path Holdings Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.